Delivery Order SPE2DB20D6037-SPE2DB24FTWW6

Award Date 9/6/24
Potential Completion Date 9/9/24
Potential Value $4.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,445.00 firm fixed-price delivery order contract covers the supply of Timolol Maleate Ophthalmic products to support the medical needs of the Department of Defense. The award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the...
This is a firm fixed-price delivery order under the DLA's SPE2DB indefinite delivery contract (IDC) valued at up to $499,999,999. The contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The order is for the pharmaceutical product Timolol Gel 5ml 1S, with a ceiling value of $1,071.30 and a period of performance through June 27, 2024. The contract supports the recurring medical supply needs of military...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide a range of pharmaceutical products and medical supplies to support military health facilities. The contract has a ceiling value of $1,381.20 and runs through June 28, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA's...
The Defense Logistics Agency Troop Support Medical awarded a $14,450 firm fixed price delivery order to DMS Pharmaceutical Group Inc. to supply timolol maleate ophthalmic solution. This order was placed against an existing indefinite-delivery/indefinite-quantity contract vehicle to fulfill requirements for this pharmaceutical product. DMS Pharmaceutical Group will perform the order from its facility in Park Ridge, Illinois, with work scheduled to be completed by August 28, 2023. No...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the supply of pharmaceutical products including medications and medical supplies. The delivery order, valued at $2,494.50, has a completion date of September 13, 2022. This order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group worth up to $499,999,999, which allows the DLA to issue...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the provision of pharmaceutical products. The contract, valued at $18,526.83, has a completion date of July 11, 2024. This award is part of a larger indefinite-delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at up to $499,999,999, which allows the DLA to issue delivery orders for a comprehensive range of...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the supply of a variety of pharmaceutical products including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables. The contract, valued at $7,104.00, has an ultimate completion date of August 28, 2024. This delivery order falls under a larger indefinite...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for $11,478.20. The contract is part of DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with DLA valued up to $499,999,999, which provides a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of Department of Defense (DoD) healthcare...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the provision of various pharmaceutical products and medical supplies. The contract has a ceiling value of $1,304.67 and a completion date of May 22, 2024. This order was issued under DMS Pharmaceutical's existing indefinite delivery contract (IDC) with DLA, valued at up to $499,999,999, which supports the recurring medical supply needs of...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order worth $9,855.93 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The order is for the supply of a Photrexa cross-linking kit, a medical product used in eye care procedures. This delivery order is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at up to $499,999,999, which covers a...
  • SPE2DB20D6037
    Indefinite Delivery Contract
  • SPE2DB20D6037-SPE2DB24FTWW6
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $4,755.38 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract is for the delivery of Timolol 0.5% gel-solution, a pharmaceutical product, with a completion date of September 9, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program, which covers a wide range of pharmaceutical items to support the medical supply needs of Department of Defense (DoD) healthcare facilities worldwide. The contract does not have a set-aside designation.

Generated 12/6/24, 9:17 AM